CareFusion Corp

CareFusion — Q4 FY2012 Earnings Presentation

18 slides from CareFusion's earnings presentation, Aug 9, 2012

  1. Slide 1: Q4 and Fiscal 2012 Investor/Analyst Call

    Exhibit 99.2 Q4 and Fiscal 2012 Investor/Analyst Call August 9, 2012 © 2012 CareFusion Corporation or one of its subsidiaries. All rights reserved.

  2. Slide 2: Forward-Looking Statements and Other Notices to Investors

    Forward-Looking Statements and Other Notices to Investors “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or

  3. Slide 3: Fiscal 2013 Guidance

    Fiscal 2013 Guidance © 2012 CareFusion Corporation or one of its subsidiaries. All rights reserved.

  4. Slide 4: Fiscal 2013 Guidance

    Fiscal 2013 Guidance August 9, 2012 FY13 Guidance FY13 Guidance Former Presentation 1 New Presentation 1 Total Revenue (constant currency) 1 – 3% 1 – 3% Medical Systems Revenue (constant currency) 1 – 3% 1 – 3% Procedural Solutions Revenue (constant currency) 0 – 2% 0 – 2% Adjusted Operating Margin²

  5. Slide 5: Fiscal 2013 Changes in Financial Presentation

    Fiscal 2013 Changes in Financial Presentation © 2012 CareFusion Corporation or one of its subsidiaries. All rights reserved.

  6. Slide 6: Changes in Non-GAAP Financial Measures

    Changes in Non-GAAP Financial Measures • M&A related intangible amortization to be excluded from adjusted financial information commencing Q1FY13. • As spinoff related charges are substantially complete, these charges will no longer be excluded from adjusted results. • Commencing Q1FY13, non-GAAP ad

  7. Slide 7: Respiratory Diagnostics

    Respiratory Diagnostics • Results of our Respiratory Diagnostics business will be included in our Respiratory Technologies business unit within Medical Systems segment commencing Q1FY13. • Previously classified within Procedural Solutions segment as “Other”. • Prior periods will be reclassified to c

  8. Slide 8: CareFusion's Three Year Financial Roadmap

    CareFusion’s Three Year Financial Roadmap © 2012 CareFusion Corporation or one of its subsidiaries. All rights reserved.

  9. Slide 9: CareFusion's Three Year Roadmap

    CareFusion’s Three Year Roadmap Conversion $1B+ share CFN markets $1B+ of Operational Mix shift to markets provide grow low single acquisition efficiency higher margin repurchase² additional digits spend initiatives products growth Share repurchase Operational Margin mix efficiencies 12 -14% M&A CAG

  10. Slide 10: Historical Financial Information

    Historical Financial Information © 2012 CareFusion Corporation or one of its subsidiaries. All rights reserved.

  11. Slide 11: Consolidated Statements of Income

    Consolidated Statements of Income FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY (in millions, except per share amounts) 2010 2011 2011 2011 2011 2011 2012 2012 2012 2012 2012 Revenue $ 3,376 790 860 842 940 3,432 824 890 919 968 3,601 Cost of Products Sold 1,685 387 427 405 452 1,671 405 444 460 479 1,788 Gross

  12. Slide 12: Reconciliation of Non-GAAP Financial Measures (FY12)

    Reconciliation of Non-GAAP Financial Measures (FY12) Adjusted Financial Data: Income Diluted from EPS from SG&A Operating Operating Continuing Continuing (in millions, except per share amounts) Expenses Expenses 5 Income Operations Operations 6 Fiscal Year Ended June 30, 2012 GAAP $ 1,026 $ 1,223 $

  13. Slide 13: Reconciliation of Non-GAAP Financial Measures (FY11)

    Reconciliation of Non-GAAP Financial Measures (FY11) Adjusted Financial Data: Income Diluted from EPS from SG&A Operating Operating Continuing Continuing 7 Expenses Expenses 6 Income Operations Operations Fiscal Year Ended June 30, 2011 GAAP $ 1,067 $ 1,277 $ 497 $ 294 $ 1.30 Restructuring and Acqui

  14. Slide 14: Reconciliation of Non-GAAP Financial Measures (FY10)

    Reconciliation of Non-GAAP Financial Measures (FY10) Adjusted Financial Data: Income Diluted from EPS from SG&A Operating Operating Continuing Continuing Expenses Expenses 7 Income Operations Operation 8 Fiscal Year Ended June 30, 2010 GAAP $ 1,090 $ 1,253 $ 450 $ 161 $ 0.72 Restructuring and Acquis

  15. Slide 15: Reconciliation of Non-GAAP Financial Measures (FY12)

    Reconciliation of Non-GAAP Financial Measures (FY12) Adjusted Effective Tax Rate: Nonrecurring Amortization of (in millions) GAAP Items ¹ Acquired Intangibles Adjusted ² Quarter Ended June 30, 2012 Income Before Income Tax $ 153 $ 7 $ 20 $ 180 Provision for Income Tax $ 46 $ - $ 7 $ 53 Effective Tax

  16. Slide 16: Reconciliation of Non-GAAP Financial Measures (FY11)

    Reconciliation of Non-GAAP Financial Measures (FY11) Adjusted Effective Tax Rate: Nonrecurring Amortization of GAAP Items ¹ Acquired Intangibles Adjusted ² Quarter Ended June 30, 2011 Income Before Income Tax $ 129 $ 30 $ 18 $ 177 Provision for Income Tax $ 33 $ 8 $ 6 $ 47 Effective Tax Rate³ 26.1%

  17. Slide 17: Reconciliation of Non-GAAP Financial Measures (FY10)

    Reconciliation of Non-GAAP Financial Measures (FY10) Adjusted Effective Tax Rate: Nonrecurring Amortization of GAAP Items¹ Acquired Intangibles Adjusted² Fiscal Year Ended June 30, 2010 Income Before Income Tax $ 345 $ 88 $ 63 $ 496 Provision for Income Tax $ 184 $ (55) $ 22 $ 151 Effective Tax Rate

  18. Slide 18: Reconciliation of Non-GAAP Financial Measures

    Reconciliation of Non-GAAP Financial Measures Adjusted EPS Outlook for Fiscal Year Ended FY13 Guidance FY13 Guidance June 30, 2013 Former 1 New Presentation 1 Presentation GAAP Diluted Earnings per Common Share from Continuing Operations $1.90 - $2.00 $1.90 - $2.00 Estimated charges for non-recurrin

CareFusion — Q4 FY2012 Earnings Presentation on 6ix